Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
European Archives of Psychiatry and Clinical Neuroscience
|
December 16, 2024
Arketamine: a scoping review of its use in humans
Gustavo C Leal, Isabel Lima-Araújo, David G Roiter, et al.
Clinical Neuropharmacology
|
January 9, 2024
Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review
Raíza Alves-Pereira, Mariana Fontes, Vivian Cordeiro, et al.
Schizophrenia Research
|
August 4, 2024
Ketamine for catatonia: A novel treatment for an old clinical challenge? A systematic review of the evidence
Ana Teresa Caliman-Fontes, Flávia Vieira, Gustavo C Leal, et al.
Cureus
|
April 26, 2024
MicroRNAs as Diagnostic Biomarkers and Predictors of Antidepressant Response in Major Depressive Disorder: A Systematic Review
Beatriz A Carneiro, Lívia N Franco Guerreiro-Costa, Daniel Lins-Silva, et al.
Harvard Review of Psychiatry
|
March 10, 2022
Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
Igor D Bandeira, Daniel H Lins-Silva, Vitor Breseghello Cavenaghi, et al.
Clinical Neuropharmacology
|
September 12, 2022
Effects of GRIN2B , GRIA1 , and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial
Graziele Beanes, Ana Teresa Caliman-Fontes, Breno Souza-Marques, et al.
Journal of Clinical Psychopharmacology
|
June 21, 2022
Esketamine for Unipolar Major Depression With Psychotic Features: A Retrospective Chart Review and Comparison With Nonpsychotic Depression
Breno Souza-Marques, Manuela Telles, Gustavo C Leal, et al.
Journal of Psychiatric Research
|
June 29, 2023
Arketamine for bipolar depression: Open-label, dose-escalation, pilot study
Igor D Bandeira, Gustavo C Leal, Fernanda S Correia-Melo, et al.
Human Psychopharmacology
|
February 18, 2022
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression
Ana Paula Jesus-Nunes, Gustavo C Leal, Fernanda S Correia-Melo, et al.
Journal of Psychiatric Research
|
May 15, 2021
Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial
Rodrigo P Mello, Mariana V F Echegaray, Ana Paula Jesus-Nunes, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
European Archives of Psychiatry and Clinical Neuroscience
|
December 16, 2024
Arketamine: a scoping review of its use in humans
Gustavo C Leal, Isabel Lima-Araújo, David G Roiter, et al.
Clinical Neuropharmacology
|
January 9, 2024
Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review
Raíza Alves-Pereira, Mariana Fontes, Vivian Cordeiro, et al.
Schizophrenia Research
|
August 4, 2024
Ketamine for catatonia: A novel treatment for an old clinical challenge? A systematic review of the evidence
Ana Teresa Caliman-Fontes, Flávia Vieira, Gustavo C Leal, et al.
Cureus
|
April 26, 2024
MicroRNAs as Diagnostic Biomarkers and Predictors of Antidepressant Response in Major Depressive Disorder: A Systematic Review
Beatriz A Carneiro, Lívia N Franco Guerreiro-Costa, Daniel Lins-Silva, et al.
Harvard Review of Psychiatry
|
March 10, 2022
Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
Igor D Bandeira, Daniel H Lins-Silva, Vitor Breseghello Cavenaghi, et al.
Clinical Neuropharmacology
|
September 12, 2022
Effects of GRIN2B , GRIA1 , and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial
Graziele Beanes, Ana Teresa Caliman-Fontes, Breno Souza-Marques, et al.
Journal of Clinical Psychopharmacology
|
June 21, 2022
Esketamine for Unipolar Major Depression With Psychotic Features: A Retrospective Chart Review and Comparison With Nonpsychotic Depression
Breno Souza-Marques, Manuela Telles, Gustavo C Leal, et al.
Journal of Psychiatric Research
|
June 29, 2023
Arketamine for bipolar depression: Open-label, dose-escalation, pilot study
Igor D Bandeira, Gustavo C Leal, Fernanda S Correia-Melo, et al.
Human Psychopharmacology
|
February 18, 2022
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression
Ana Paula Jesus-Nunes, Gustavo C Leal, Fernanda S Correia-Melo, et al.
Journal of Psychiatric Research
|
May 15, 2021
Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial
Rodrigo P Mello, Mariana V F Echegaray, Ana Paula Jesus-Nunes, et al.
Page
of 2